Publikationer/ Publications

Implementation of National Guidelines increased survival in advanced ovarian cancer – A population-based nationwide SweGCG study

Pernilla Dahm-Kähler, Erik Holmberg, Mikael Holtenman, Angelique Flöter Rådestad, Christer Borgfeldt, Elisabet Hjerpe, Janusz Marcickiewicz, Maria Bjurberg, Bengt Tholander, Kristina Hellman, Preben Kjølhede, Thomas Högberg, Per Rosenberg, Elisabeth Åvall-Lundqvist, Karin Stålberg

Primary treatment and relative survival by stage and age in vulvar squamous cell carcinoma: A population-based SweGCG study

Hellman K, Holmberg E, Bjurberg M, Borgfeldt C, Dahm-Kähler P, Flöter Rådestad A, Hjerpe E, Högberg T, Marcickiewicz J, Rosenberg P, Stålberg K, Tholander B, Kjølhede P, Åvall-Lundqvist E.Gynecol Oncol. 2020 Dec;159(3):663-671. doi: 10.1016/j.ygyno.2020.09.027. Epub 2020 Sep 26.PMID: 32988623

Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study.

Bjurberg M, Holmberg E, Borgfeldt C, Flöter-Rådestad A, Dahm-Kähler P, Hjerpe E, Högberg T, Kjølhede P, Marcickiewicz J, Rosenberg P¹, Stålberg K, Tholander B, Hellman K, Åvall-Lundqvist E.

Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31474-X. doi: 10.1016/j.ygyno.2019.08.022. [Epub ahead of print]

Lymphovascular space invasion as a predictive factor for lymph node metastases and survival in endometrioid endometrial cancer – a Swedish Gynecologic Cancer Group (SweGCG) study.

Stålberg K, Bjurberg M, Borgfeldt C, Carlson J, Dahm-Kähler P, Flöter-Rådestad A, Hellman K, Hjerpe E, Holmberg E, Kjølhede P, Marcickiewicz J, Rosenberg P, Tholander B, Åvall-Lundqvist E, Högberg T.

Acta Oncol. 2019 Aug 2:1-6. doi: 10.1080/0284186X.2019.1643036. [Epub ahead of print] PMID:31373248

Lymph node metastases as only qualifier for stage IV serous ovarian cancer confers longer survival than other sites of distant disease – a Swedish Gynecologic Cancer Group (SweGCG) study.

Hjerpe E, Staf C, Dahm-Kähler P, Stålberg K, Bjurberg M, Holmberg E, Borgfeldt C, Tholander B, Hellman K, Kjølhede P, Högberg T, Rosenberg P, Åvall-Lundqvist E.

Acta Oncol. 2018 Mar;57(3):331-337. doi: 10.1080/0284186X.2017.1400691. Epub 2017 Nov 12. PMID: 29130381

Data quality in the Swedish Quality Register of Gynecologic Cancer – a Swedish Gynecologic Cancer Group (SweGCG) study.

Rosenberg P, Kjølhede P, Staf C, Bjurberg M, Borgfeldt C, Dahm-Kähler P, Hellman K, Hjerpe E, Holmberg E, Stålberg K, Tholander B, Åvall Lundqvist E, Högberg T.

Acta Oncol. 2018 Mar;57(3):346-353. doi: 10.1080/0284186X.2017.1366048. Epub 2017 Aug 22. PMID: 28828920


Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study-On behalf of the Swedish Gynecological Cancer Group. Stålberg K, Kjølhede P, Bjurberg M, Borgfeldt C, Dahm-Kähler P, Falconer H, Holmberg E, Staf C, Tholander B, Åvall-Lundqvist E, Rosenberg P, Högberg T. Int J Cancer. 2017 Jun 15;140(12):2693-2700. doi: 10.1002/ijc.30707. Epub 2017 Apr 12. PMID: 28340503

Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin – on behalf of the Swedish gynecological cancer group (SweGCG).

Dahm-Kähler P, Borgfeldt C, Holmberg E, Staf C, Falconer H, Bjurberg M, Kjölhede P, Rosenberg P, Stålberg K, Högberg T, Åvall-Lundqvist E.

Gynecol Oncol. 2017 Jan;144(1):167-173. doi: 10.1016/j.ygyno.2016.10.039. Epub 2016 Nov 3. PMID: 27817932

Dela det här:

Gilla